Potassium
In clinical developmentAlso known as K, Kalium, Neutra-Phos-K, Potasio+5 more
K, Kalium, Neutra-Phos-K, Potasio, K - Potassium, Potassium metal, Potassium, elemental, Potassium, metal, potassium(1+).
Recent clinical, regulatory, research and industry developments relating to this drug.
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration.
ASPEN Consensus Recommendations for Refeeding Syndrome.
The Physiology of the Gastric Parietal Cell.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Recent completions
Trials that read out recently, adding to the completed evidence base.
Hypertension Prevention Trial (HPT) Feasibility Study
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Brain : a journal of neurology1
- Frontiers in endocrinology1
- Kidney international1
- Nature communications1
- Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition1
- Physiological reviews1
- Adams SC1
- Ayers P1
- Bataveljic D1
- Bemelmans AP1
- Berdahl GJ1
- Blanchard A1
- Bockenhauer D1
- Bolignano D1
- Akron Children's Hospital1
- Boston Children's Hospital1
- Center for Basic and Translational Neuroscience1
- Center for Interdisciplinary Research in Biology1
- Center for Molecular Medicine1
- Center for Translational Neuromedicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials